sustain 6 trial semaglutide π SUSTAIN-6 (NEJM 2016) β the safety that became a landmark., In 3,297 patients with type 2 diabetes at high CV risk, reduced:, β’ 3-point MACE 26% (HR 0.74), β’ Nonfatal stroke 39% Cardiovascular Outcomes, Safety, and Tolerability
Pay in 4 interest-free payments of $7.00 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Aug 11 - Aug 16
















:max_bytes(150000):strip_icc()/VW-Health-Ozembic-Injection-site-V2-f0e98eb1833f48e898d8a19800fb515f.jpg)









